Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Essa Pharma Inc.
DescriptionSelective blocker of the N-terminus of the androgen receptor
Molecular Target Androgen receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationProstate cancer
Indication DetailsTreat metastatic castration-resistant prostate cancer (CRPC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today